FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LINAGLIPTIN HYDROXYETHYLPHTHALIMIDE ANALOG
异名/同义词(R)-N1-(1-(7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)PIPERIDIN-3-YL)-N2-(2-HYDROXYETHYL)PHTHALAMIDE [IUPAC]
1,2-BENZENEDICARBOXAMIDE, N1-((3R)-1-(7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)-3-PIPERIDINYL)-N2-(2-HYDROXYETHYL)- [INDEX-NAME]
LINAGLIPTIN HYDROXYETHYLPHTHALIMIDE ANALOG
LINAGLIPTIN HYDROXYETHYLPHTHALIMIDE ANALOG [USP Nickname]
CAS登记号2074688-80-3
物质唯一标识(Unique Ingredient Identifier)2C6YGZ385D
分子式C35H37N9O5
国际化合物标识(International Chemical Identifier,InChI)ZFNQEMCRVBLZQE-HSZRJFAPSA-N
SMILESCC#CCn1c2c(nc1N3CCC[C@H](C3)NC(=O)c4ccccc4C(=O)NCCO)n(C)c(=O)n(Cc5nc(C)c6ccccc6n5)c2=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
    扩展资源
    ©2006-2024 Drugfuture->FDA Global Substance Registration System